DiaMedica Therapeutics (DMAC) SEC Filings & 10K Form

$2.58
+0.05 (+1.98%)
(As of 04/26/2024 ET)

Recent DiaMedica Therapeutics SEC Filings

DateFilerForm TypeView
04/10/2024
3:36 PM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
11:15 PM
DiaMedica Therapeutics (Filer)
Form EFFECT
04/04/2024
5:12 AM
DiaMedica Therapeutics (Filer)
Form ARS
04/04/2024
5:05 AM
DiaMedica Therapeutics (Filer)
Form DEF 14A
04/04/2024
5:06 AM
DiaMedica Therapeutics (Filer)
Form DEFA14A
03/21/2024
3:47 PM
DiaMedica Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/23/2024
3:23 PM
DiaMedica Therapeutics (Issuer)
Lorianne Masuoka K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:00 PM
DiaMedica Therapeutics (Issuer)
Kuntz Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:05 PM
DiaMedica Therapeutics (Issuer)
Semba Charles Pauling (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:47 PM
DiaMedica Therapeutics (Issuer)
Pilnik Richard D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:39 PM
DiaMedica Therapeutics (Issuer)
Parsons James T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
3:37 PM
DiaMedica Therapeutics (Issuer)
Wambeke David J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:15 PM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
3:16 PM
DiaMedica Therapeutics (Filer)
Form 424B3
07/09/2023
11:15 PM
DiaMedica Therapeutics (Filer)
Form EFFECT
06/30/2023
3:16 PM
DiaMedica Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/27/2023
3:10 PM
DiaMedica Therapeutics (Issuer)
STAHLBERG JAN (Reporting)
TRILL AB (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2023
3:11 PM
DiaMedica Therapeutics (Issuer)
TomEnterprise AB (Reporting)
TomEqt Private AB (Reporting)
Von Koch Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
3:11 PM
DiaMedica Therapeutics (Subject)
TRILL AB (Filed by)
Form SC 13G/A
06/27/2023
3:11 PM
DiaMedica Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
06/27/2023
3:12 PM
DiaMedica Therapeutics (Subject)
TomEnterprise AB (Filed by)
Form SC 13G/A
06/26/2023
3:42 PM
DiaMedica Therapeutics (Issuer)
Giuffre Randall Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:34 PM
DiaMedica Therapeutics (Issuer)
Pauls Dietrich John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:14 PM
DiaMedica Therapeutics (Issuer)
Wambeke David J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:21 PM
DiaMedica Therapeutics (Issuer)
Kellen Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:26 PM
DiaMedica Therapeutics (Issuer)
Semba Charles Pauling (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
3:03 PM
DiaMedica Therapeutics (Issuer)
Pilnik Richard D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
4:10 PM
DiaMedica Therapeutics (Issuer)
JACINTO RICHARD II (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/23/2023
4:13 PM
DiaMedica Therapeutics (Subject)
JACINTO RICHARD II (Filed by)
Form SC 13G/A
06/21/2023
7:42 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
7:25 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
7:16 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2023
4:16 PM
Daves Julie VanOrsdel (Reporting)
DiaMedica Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
5:18 PM
DiaMedica Therapeutics (Issuer)
Kuntz Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
7:30 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2023
7:30 AM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2023
3:30 PM
DiaMedica Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:DMAC) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners